221 related articles for article (PubMed ID: 15024079)
41. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
42. Convergence of Wnt signaling and steroidogenic factor-1 (SF-1) on transcription of the rat inhibin alpha gene.
Gummow BM; Winnay JN; Hammer GD
J Biol Chem; 2003 Jul; 278(29):26572-9. PubMed ID: 12732619
[TBL] [Abstract][Full Text] [Related]
43. beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland.
Michaelson JS; Leder P
Oncogene; 2001 Aug; 20(37):5093-9. PubMed ID: 11526497
[TBL] [Abstract][Full Text] [Related]
44. Androgen receptor interactions with Oct-1 and Brn-1 are physically and functionally distinct.
González MI; Tovaglieri A; Robins DM
Mol Cell Endocrinol; 2002 Apr; 190(1-2):39-49. PubMed ID: 11997177
[TBL] [Abstract][Full Text] [Related]
45. LEF1-mediated regulation of Delta-like1 links Wnt and Notch signaling in somitogenesis.
Galceran J; Sustmann C; Hsu SC; Folberth S; Grosschedl R
Genes Dev; 2004 Nov; 18(22):2718-23. PubMed ID: 15545629
[TBL] [Abstract][Full Text] [Related]
46. Synergistic cooperation between the beta-catenin signaling pathway and steroidogenic factor 1 in the activation of the Mullerian inhibiting substance type II receptor.
Hossain A; Saunders GF
J Biol Chem; 2003 Jul; 278(29):26511-6. PubMed ID: 12724325
[TBL] [Abstract][Full Text] [Related]
47. Regulation of Wnt signaling by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin.
Zorn AM; Barish GD; Williams BO; Lavender P; Klymkowsky MW; Varmus HE
Mol Cell; 1999 Oct; 4(4):487-98. PubMed ID: 10549281
[TBL] [Abstract][Full Text] [Related]
48. LKB1 (XEEK1) regulates Wnt signalling in vertebrate development.
Ossipova O; Bardeesy N; DePinho RA; Green JB
Nat Cell Biol; 2003 Oct; 5(10):889-94. PubMed ID: 12973359
[TBL] [Abstract][Full Text] [Related]
49. Microphthalmia-associated transcription factor in the Wnt signaling pathway.
Saito H; Yasumoto K; Takeda K; Takahashi K; Yamamoto H; Shibahara S
Pigment Cell Res; 2003 Jun; 16(3):261-5. PubMed ID: 12753399
[TBL] [Abstract][Full Text] [Related]
50. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
51. A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4.
Amir AL; Barua M; McKnight NC; Cheng S; Yuan X; Balk SP
J Biol Chem; 2003 Aug; 278(33):30828-34. PubMed ID: 12799378
[TBL] [Abstract][Full Text] [Related]
52. Wnt signaling during development of the gastrointestinal tract.
Theodosiou NA; Tabin CJ
Dev Biol; 2003 Jul; 259(2):258-71. PubMed ID: 12871700
[TBL] [Abstract][Full Text] [Related]
53. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L
Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853
[TBL] [Abstract][Full Text] [Related]
54. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.
Müller-Tidow C; Steffen B; Cauvet T; Tickenbrock L; Ji P; Diederichs S; Sargin B; Köhler G; Stelljes M; Puccetti E; Ruthardt M; deVos S; Hiebert SW; Koeffler HP; Berdel WE; Serve H
Mol Cell Biol; 2004 Apr; 24(7):2890-904. PubMed ID: 15024077
[TBL] [Abstract][Full Text] [Related]
55. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
[TBL] [Abstract][Full Text] [Related]
56. Developmental expression of Wnt signaling factors in mouse brain.
Coyle-Rink J; Del Valle L; Sweet T; Khalili K; Amini S
Cancer Biol Ther; 2002; 1(6):640-5. PubMed ID: 12642687
[TBL] [Abstract][Full Text] [Related]
57. Instructive role of Wnt/beta-catenin in sensory fate specification in neural crest stem cells.
Lee HY; Kléber M; Hari L; Brault V; Suter U; Taketo MM; Kemler R; Sommer L
Science; 2004 Feb; 303(5660):1020-3. PubMed ID: 14716020
[TBL] [Abstract][Full Text] [Related]
58. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
Ishitani T; Ninomiya-Tsuji J; Matsumoto K
Mol Cell Biol; 2003 Feb; 23(4):1379-89. PubMed ID: 12556497
[TBL] [Abstract][Full Text] [Related]
59. Brachyury is a target gene of the Wnt/beta-catenin signaling pathway.
Arnold SJ; Stappert J; Bauer A; Kispert A; Herrmann BG; Kemler R
Mech Dev; 2000 Mar; 91(1-2):249-58. PubMed ID: 10704849
[TBL] [Abstract][Full Text] [Related]
60. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]